Literature DB >> 32459405

Not So Fast: Recent Successes and Failures in Treating Depression.

Bashkim Kadriu1,2, Zhi-De Deng2, Christoph Kraus2, Ioline D Henter2, Sarah H Lisanby2, Carlos A Zarate2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32459405      PMCID： PMC7681914          DOI： 10.4088/JCP.19ac13138

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  41 in total

1.  Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.

Authors:  Stephen Kanes; Helen Colquhoun; Handan Gunduz-Bruce; Shane Raines; Ryan Arnold; Amy Schacterle; James Doherty; C Neill Epperson; Kristina M Deligiannidis; Robert Riesenberg; Ethan Hoffmann; David Rubinow; Jeffrey Jonas; Steven Paul; Samantha Meltzer-Brody
Journal:  Lancet       Date:  2017-06-12       Impact factor: 79.321

2.  Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

Authors:  Nancy DiazGranados; Lobna A Ibrahim; Nancy E Brutsche; Rezvan Ameli; Ioline D Henter; David A Luckenbaugh; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-07-13       Impact factor: 4.384

Review 3.  Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders.

Authors:  C A Zarate; R Machado-Vieira
Journal:  Mol Psychiatry       Date:  2017-01-10       Impact factor: 15.992

Review 4.  Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

Authors:  D Jeffrey Newport; Linda L Carpenter; William M McDonald; James B Potash; Mauricio Tohen; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2015-10       Impact factor: 18.112

5.  Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Authors:  Ella J Daly; Madhukar H Trivedi; Adam Janik; Honglan Li; Yun Zhang; Xiang Li; Rosanne Lane; Pilar Lim; Anna R Duca; David Hough; Michael E Thase; John Zajecka; Andrew Winokur; Ilona Divacka; Andrea Fagiolini; Wieslaw J Cubala; István Bitter; Pierre Blier; Richard C Shelton; Patricio Molero; Husseini Manji; Wayne C Drevets; Jaskaran B Singh
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

Review 6.  GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.

Authors:  Joseph R Moskal; Ronald Burch; Jeffrey S Burgdorf; Roger A Kroes; Patric K Stanton; John F Disterhoft; J David Leander
Journal:  Expert Opin Investig Drugs       Date:  2013-11-20       Impact factor: 6.206

7.  Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Authors:  James W Murrough; Andrew M Perez; Sarah Pillemer; Jessica Stern; Michael K Parides; Marije aan het Rot; Katherine A Collins; Sanjay J Mathew; Dennis S Charney; Dan V Iosifescu
Journal:  Biol Psychiatry       Date:  2012-07-27       Impact factor: 13.382

8.  Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans.

Authors:  Samuel T Wilkinson; Edeanya Agbese; Douglas L Leslie; Robert A Rosenheck
Journal:  Psychiatr Serv       Date:  2018-02-01       Impact factor: 3.084

Review 9.  Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy.

Authors:  Caroline Caddy; Giovanni Giaroli; Thomas P White; Sukhwinder S Shergill; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2014-04

10.  Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.

Authors:  Gerard Sanacora; Michael R Johnson; Arif Khan; Sarah D Atkinson; Robert R Riesenberg; Juan P Schronen; Michael A Burke; John M Zajecka; Luis Barra; Hong-Lin Su; Joel A Posener; Khanh H Bui; Michael C Quirk; Timothy M Piser; Sanjay J Mathew; Sanjeev Pathak
Journal:  Neuropsychopharmacology       Date:  2016-09-29       Impact factor: 7.853
View more
  1 in total

Review 1.  Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road.

Authors:  Bashkim Kadriu; Laura Musazzi; Jenessa N Johnston; Lisa E Kalynchuk; Hector J Caruncho; Maurizio Popoli; Carlos A Zarate
Journal:  Drug Discov Today       Date:  2021-08-03       Impact factor: 8.369
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.